Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.00 is 100% below its 1-year average of 0.02, near the low end of its 1-year range (0.00–0.05).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
N/A
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 773 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$11.55M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$11.12M
Debt to Equity Ratio
0.03
TTM Avg
0.03
3Y Avg
0.07
5Y Avg
0.06
Market Cap
$11.08M
Debt to Equity Ratio
0.02
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.02
Market Cap
$11.02M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.01
Market Cap
$11.00M
Debt to Equity Ratio
0.09
TTM Avg
0.06
3Y Avg
1.84
5Y Avg
2.48
Market Cap
$11.77M
Debt to Equity Ratio
1.10
TTM Avg
0.92
3Y Avg
1.14
5Y Avg
0.73
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $11.36M | 0.00 | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.55M | 0.00 | 0.00 | 0.01 | 0.01 |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | 0.03 | 0.03 | 0.07 | 0.06 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | 0.02 | 0.01 | 0.01 | 0.02 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | 0.00 | 0.00 | 0.00 | 0.01 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | 0.09 | 0.06 | 1.84 | 2.48 |
| IRIDEX Corporation (IRIX)vs › | $11.77M | 1.10 | 0.92 | 1.14 | 0.73 |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 0.01 | 0.21 | 0.55 | 1.02 |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.03 | 0.03 | 0.35 | 0.79 |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | 0.00 | 0.00 | 0.88 | 0.58 |
Debt/Equity
0.00
Current Ratio
4.96
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.03 |
| 2025-09-30 | 0.05 |
